deltatrials
Completed EARLY_PHASE1 INTERVENTIONAL 3-arm NCT01906346

Impact of a Non-Drug Choice on Cocaine Reinforcement

Sponsor: Joshua A. Lile, Ph.D.

Interventions Cocaine Placebo
Updated 8 times since 2017 Last updated: Apr 19, 2019 Started: Jan 31, 2014 Primary completion: Jun 30, 2015 Completion: Jun 30, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01906346, this EARLY_PHASE1 trial focuses on Cocaine Dependence and remains completed. Sponsored by Joshua A. Lile, Ph.D., it has been updated 8 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshotCompleted~Apr 2017 – ~Jun 2018 · 14 months · monthly snapshotCompleted~Jun 2018 – ~Jun 2019 · 12 months · monthly snapshotCompleted~Jun 2019 – ~Jan 2021 · 19 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed EARLY_PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed EARLY_PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed EARLY_PHASE1

  4. Jun 2019 — Jan 2021 [monthly]

    Completed EARLY_PHASE1

  5. Jun 2018 — Jun 2019 [monthly]

    Completed EARLY_PHASE1

Show 3 earlier versions
  1. Apr 2017 — Jun 2018 [monthly]

    Completed EARLY_PHASE1

  2. Feb 2017 — Apr 2017 [monthly]

    Completed EARLY_PHASE1

    Phase: Phase 0EARLY_PHASE1

  3. Jan 2017 — Feb 2017 [monthly]

    Completed Phase 0

    First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Joshua A. Lile, Ph.D.
Data source: University of Kentucky

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations